Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
32,452,015
-
Share change
-
-731,063
-
Total reported value
-
$2,408,764,108
-
Put/Call ratio
-
184%
-
Price per share
-
$74.23
-
Number of holders
-
151
-
Value change
-
-$37,574,515
-
Number of buys
-
85
-
Number of sells
-
68
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q1 2015
As of 31 Mar 2015,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,452,015 shares.
The largest 10 holders included
FMR LLC, NEA Management Company, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Partner Fund Management, L.P., Palo Alto Investors, LLC, VANGUARD GROUP INC, OPPENHEIMER FUNDS INC, BlackRock Fund Advisors, ORBIMED ADVISORS LLC, and Redmile Group, LLC.
This page lists
151
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.